Manosphere Influencer Traced to Record MHRA Fake Weight-Loss Jab Raids

The Medicines and Healthcare products Regulatory Agency has seized 12,000 unlicensed weight-loss doses from a Grade II-listed Georgian house near Northampton, yet authorities have remained silent on ownership. A Channel 4 News digital-forensics investigation published on 6 August 2026 now traces the operation to Amio Talio, a Northampton-based manosphere influencer whose brother directed a company at the earlier raided warehouse.

Manosphere Influencer Traced to Britain’s Largest Fake Weight-Loss Drug Factory in Northamptonshire

Northampton, UK – 7 August 2026 — On 28 May 2026 the MHRA Criminal Enforcement Unit, supported by Northamptonshire Police, raided Moulton Grange, a 12-bedroom country house seven miles north of Northampton town centre. Officers recovered 12,000 doses of unlicensed retatrutide and tirzepatide, the largest single seizure of such products ever recorded by the agency.

Record Raids Expose Organised Criminal Network

The Moulton Grange operation followed an earlier raid on Unit 5 Tenter Road, Moulton Park industrial estate, three miles north of Northampton, in October 2025. There the MHRA seized 2,000 pre-made injectable pens, £20,000 in cash and manufacturing equipment used to produce the “Alluvi” brand. Both sites form part of an ongoing MHRA investigation into an organised criminal network that also prompted raids in Lincolnshire and Nottingham in February 2026.

Moulton Grange itself, with its central section dating to around 1825, stands as an unlikely setting for such activity. The 28-acre estate, complete with lawns, lakes and sheep-grazed pastures, features a billiards room and roaming peacocks. Sold for £2.2 million in 2017, it is owned by Faiz Hameed, 61, and Rashda Hameed, 59, directors of Moulton Grange Limited. The couple informed the BBC that the raid was confined to a separately let annexe occupied by tenants, distancing the main house from the criminal enterprise.

The October 2025 Tenter Road raid marked what the MHRA described as the world’s first illegal manufacturing facility for weight-loss jabs. Rather than counterfeiting established brands, the criminals created their own, Alluvi Healthcare. This represented the largest single seizure of trafficked weight-loss medicines ever recorded by any law enforcement agency worldwide, underscoring a shift towards fully independent illicit production lines.

Further raids in Lincolnshire and Nottingham in February 2026 have been confirmed by the MHRA as connected to the same network. These operations reveal a coordinated infrastructure spanning multiple counties, with manufacturing, distribution and online sales tightly integrated. The pattern echoes concerns seen in other parts of the Midlands and extends to distribution nodes reported in the North West, where similar supply routes have been monitored by local trading standards teams.

The Alluvi Brand and Telegram Marketplace

The Alluvi Telegram account amassed 14,146 subscribers, promoting 25 per cent discounts and accepting payments via bank transfer, PayPal or cryptocurrency. A BBC test purchase placed through the channel never arrived, highlighting the risks consumers face when dealing with unregulated sellers. The platform’s reach demonstrates how encrypted messaging services have become primary conduits for illicit pharmaceuticals.

Retatrutide, nicknamed the “Godzilla jab” and undergoing clinical trials by Eli Lilly, remains unapproved in both the US and UK. Early studies suggest potential weight loss of up to 24 per cent of body weight. The seized products, however, were not manufactured by Eli Lilly; tirzepatide (Mounjaro) is approved but must originate from licensed laboratories, a standard these counterfeit versions failed to meet.

Encrypted channels allow rapid scaling of sales across regions, with orders reportedly reaching buyers in London and further afield in Scotland and Wales. This decentralised model reduces the chance of interception while maintaining direct contact with end users who often seek discretion.

Medicines Regulation and the Online Loophole

Prescription-only medicines in the UK are governed by strict rules under the Human Medicines Regulations 2012, which prohibit advertising to the public and require licensed supply chains. The MHRA holds powers to seize products and pursue criminal enforcement, yet social media platforms continue to host promotions that blur the line between legitimate clinics and unlicensed sellers. These gaps allow rapid dissemination of offers that bypass traditional pharmacy safeguards.

Other jurisdictions have adopted more proactive measures. Australia requires verified pharmacy credentials for any online medicine advertisement, while several EU states mandate pre-approval of digital content by national regulators. In contrast, the UK framework relies heavily on post-publication takedowns, leaving windows of opportunity for operators who relocate content swiftly across accounts and platforms.

What This Means for the UK

UCL research shows 1.6 million UK adults used weight-loss jabs in 2025, most through private prescriptions costing £150–£300 monthly. Around 15 per cent obtained medicines from unlicensed sources. Dr Jamie Green, a GP at Delapre Medical Centre in Northampton, warned that cheap alternatives risk broken needles and unknown contaminants. The family of Karen McGonigal from Salford, who died in May 2025 after receiving an unlicensed jab, met then-Health Secretary Wes Streeting in February 2026.

NHS prescribing constraints have fuelled a private clinic boom, yet social media advertising of prescription medicines continues largely unchecked. This regulatory gap allows unlicensed providers to target vulnerable users seeking rapid results, often bypassing medical oversight entirely.

Andy Morling has cautioned that production methods may evolve further as patents on tirzepatide expire and cheap generics become available. Such developments could lower barriers for criminal networks, expanding the scale of illicit manufacturing beyond current levels.

The consequences are felt unevenly across the country. In London, private clinics report rising numbers of patients presenting with adverse reactions from unknown sources, while services in the North West and parts of Wales have noted similar patterns among younger adults. Scotland’s regulatory bodies have begun joint awareness campaigns with the MHRA, recognising that cross-border online sales ignore traditional geographic boundaries.

Digital Trail Leads to Manosphere Influencer Amio Talio

Channel 4’s investigation followed Telegram accounts and company records to Amio Talio, real name Amar Tariq, who runs an Andrew Tate-style wealth academy on Instagram to 116,000 followers. His brother, Fasial Tariq, is listed as director of Wholesale Supplements Limited, the company registered at the Tenter Road unit four months before the October 2025 raid. Northampton Magistrates Court froze Fasial Tariq’s Barclays account containing £11,706 under the Proceeds of Crime Act in January 2026.

Amio Talio co-founded the Paradox Metaverse crypto game with his brother, securing a livestream with iShowSpeed, who commands more than 43 million followers. The project later drew scrutiny when Coffeezilla labelled it a “Ponzi” scheme and the brothers “scammers”. Fasial Tariq had two other firms registered at the Tenter Road address, both now dissolved; he is not one of the two men arrested and has not responded to BBC questions.

The Channel 4 video chapters examine the Andrew Tate model, Coffeezilla’s exposé involving iShowSpeed, Amio’s brother, the digital footprint, the seized gun and ongoing operations, alongside rights of reply. These elements illustrate how manosphere influencers blend aspirational content with monetised schemes that can extend into high-risk criminal territory.

The Manosphere Economy and Online Scam Monetisation

Wealth academies and crypto schemes have become central features of the manosphere economy, where luxury imagery and promises of rapid financial independence are packaged for young British men. The Andrew Tate template, replicated across Instagram and Telegram, combines motivational messaging with paid courses and investment opportunities that often operate at the edge of regulatory oversight. Participants are encouraged to project success through visible consumption, creating a feedback loop that draws in further recruits.

These platforms frequently intersect with higher-risk activities when initial monetisation strategies falter. Young men in the Midlands and northern cities, facing limited economic mobility, are particularly exposed to narratives that frame regulatory boundaries as obstacles rather than protections. The proximity of such content to pharmaceutical sales channels highlights how fragmented enforcement allows influence networks to diversify into multiple revenue streams with minimal friction.

Reaction and Response from Regulators and Experts

Andy Morling, head of the MHRA Criminal Enforcement Unit, stated after the Moulton Grange raid: “It’s just you and a syringe full of risk.” He added there is “no hiding place for those who cynically put the public’s health at risk for profit.” The MHRA has removed 400 social media posts and websites selling illicit jabs. In 2025 the agency confiscated 24 million doses of illicit medicines, though weight-loss products accounted for less than one per cent.

These warnings arrive against a backdrop of rising demand driven by social media and limited NHS access. Experts note that the combination of high private prescription costs and aggressive online marketing creates fertile ground for criminal substitution.

The Bottom Line — What Comes Next

The two 29-year-old men arrested at Moulton Grange were released under investigation. Fasial Tariq has not responded to questions about his connection to the Alluvi operation. As patents on tirzepatide expire, Andy Morling warned that illegal production methods may evolve. The Channel 4 News investigation, “Who is the manosphere influencer linked to fake weight loss drugs raid?”, aired on 6 August 2026 and is embedded above.

Looking ahead, sustained pressure on both the supply of illicit medicines and the monetisation models that sustain influencer networks will be required. Without coordinated action across platforms, financial regulators and health agencies, the infrastructure uncovered in Northamptonshire risks re-emerging in new forms, particularly as demand continues to outstrip regulated supply in regions from London to the North West and beyond.

By Erica Thornton, Staff Writer

This article was produced with AI-assisted research and editorial support. Reporting is based on sources cited in the article.